Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of a Marine OXYgen Carrier for Organ Preservation : a Multicenter Randomized Study Evaluating the Efficacy of HEMO2life® Versus Standard of Care in Renal Transplantation

NCT04181710 is registered in ClinicalTrials.gov with University Hospital, Brest as lead sponsor.

NCT NCT04181710
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04181710 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of a Marine OXYgen Carrier for Organ Preservation : a Multicenter Randomized Study Evaluating the Efficacy of HEMO2life® Versus Standard of Care in Renal Transplantation
Lead sponsor
University Hospital, Brest
Phase
Not applicable
Overall status
Completed
Start date
July 4, 2020
Completion date
September 11, 2023
Enrollment
490 (actual)
Sites
32

Conditions

As the registry lists them; a condition with its own page is linked.

end stage renal diseases